Who, When, and How: Watchful Waiting in the ERSPC Rotterdam

Jeroen J Lodder1, Esmée F H Mulder1, Sebastiaan Remmers1

  • 1Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

Summary

Watchful waiting (WW) for prostate cancer requires individualized follow-up. Long-term data shows significant differences in androgen deprivation therapy (ADT) initiation rates based on risk group, highlighting the need for tailored monitoring strategies.

Related Concept Videos